Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to dissemintate knowledge & skills of Acute Cardiovascular Care
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission: To promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our goal is to reduce the burden in cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our Mission is "to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death"
To improve quality of life and logevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
Working Groups goals is to stimulate and disseminate scientific knowledge in different fields of cardiology.
ESC Councils goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
3-5 November 2011 Rome, Italy
The symposium was designed to address the pathophysiology, diagnosis and treatment of cardiometabolic risk and discuss its impact in clinical practice.
This three-day programme offered a comprehensive update on the cardiometabolic risk presented by a distinguished international teaching Faculty.
Broad spectrums of important topics have been magistrally covered by the experts including arterial aging from its genetic and environmental determinants to assessment and putative management. Then, the role of classical and novel risk factors has been addressed giving particular evidence to the concept of dysglycemia, abdominal obesity and inflammatory pathways.
Several sessions were dedicated to address how we can improve evidence-based management of cardiometabolic risk focusing on new redox targets, utility of vascular imaging and biomarkers as well as the crucial issue related to the implementation of guideline targets. Furthermore, the putative strategies which go beyond glycemic control, with a window on peripheral arterial disease and nephroprotection, were also discussed.
One session was dealing with the two main actors on the battle field: lipids and diabetes, addressing the need for intense glucose and LDL-lowering as well as lipid management beyond LDL, focusing on the importance for individualized treatments.
Two special lectures were dedicated to the recent ESC Practice Guidelines on Diabetes & Cardiovascular Disease and Diagnosis & Treatment of Peripheral Arterial Diseases.
I am delighted to announce that the Proceedings of our Symposium on “Cardiometabolic risk and Vascular Diseases – from Mechanisms to Treatment” will be published in Current Vascular Pharmacology soon.
I do believe that our goal to promote an interactive learning environment under the umbrella of the Working Group on Peripheral Circulation has been achieved. Undoubtedly, it has also emerged from the very lively discussions the need for networking among cardiologists, angiologists, internists and diabetologists to implement a successful collaboration across specialty borders.
Prof. Francesco Cosentino
ESC Working Group on Peripheral Circulation